We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types.
Hisham Hamadeh, Ph.D. Vice President, Global Head of Data Sciences
We especially appreciated the high level of expertise and support provided by Genedata, which enabled us to optimize every stage of our analytical processes—while incorporating industry best practices—and quickly generate high-quality results.
Juliet Padden Ph.D. Laboratory Head Analytical Development
During our initial deployment, we recorded quantifiable increases in productivity. The number of results posted to our data warehouse more than doubled, indicating that we could capture results from many more experiments, while the cost of running day-to-day operations decreased.
Steve Rees Vice President, Discovery Biology, Discovery Sciences
The Biologics Data Platform supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process.
Heiner Apeler, Ph.D. Director of Molecular and Antibody Biology
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
Sergio Rotstein, Ph.D. Director of Research Business Technology
Genedata enables us to integrate a wide variety of complex data generated by novel experimental workflows so we can gain a holistic molecular understanding of production cells with the goal of developing high performing bioproduction processes.
Ruth Wagner, Ph.D. Group Manager of Cell Line Engineering
We need to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects. We chose Genedata because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines.
Kimio Terao Department Manager of Clinical Pharmacology
We aimed to extend automation and further enhance the efficiency of our cell line, upstream and bioanalytical development operations, and quickly realized that Genedata addresses many of our requirements off-the-shelf, eliminating the need for expensive customization.
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in next-generation biotechnology innovations. Genedata was our obvious choice.
Harald Bradl, Ph.D. Director, Cell Culture and Process Sciences
Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process – right through from the immunization of transgenic mice, to lead selection, molecular modification and final candidate assessments.